GlassScriptPhysician profile
Gisela Trigo
NPI 1366426561
$2,924.61
in general payments reported to CMS, 2019-2025
20 companies · $429 in 2025
The $429 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $275 · 2021: $289 · 2022: $263 · 2023: $403 · 2024: $836 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,668.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $865.45 | 2022-2025 | Micra, Cobalt Dr Mri Surescan, Linq II |
| Abbott Laboratories | $708.40 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $549.18 | 2022-2025 | Watchman Flx |
| Pfizer INC. | $117.29 | 2019-2024 | |
| Amarin Pharma, INC. | $112.91 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $86.54 | 2023 | Optimizer |
| Merck Sharp & Dohme LLC | $80.53 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $68.32 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $53.76 | 2021-2024 | Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.61 | 2022-2024 | Lifevest |
| Welch Allyn | $38.13 | 2021 | |
| Novartis Pharmaceuticals Corporation | $35.04 | 2024-2025 | |
| Amgen INC. | $29.35 | 2022 | |
| Atricure, INC. | $23.86 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $21.89 | 2023 | Arcalyst |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $21.88 | 2019 | |
| Esperion Therapeutics, INC. | $18.21 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $17.59 | 2023 | Inpefa |
| Biosense Webster, INC. | $15.37 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gisela Trigo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.